The Ordinary's Multi-Peptide Serum for Hair Density is the most defensible product in the hype tier, mostly because it's honest about being cheap and doesn't cost $88. It's a lightweight leave-in serum built on trademarked peptide complexes — Redensyl, Procapil, Capixyl, AnaGain — plus caffeine, applied to the scalp once a day. Those actives have some supplier-generated data suggesting density support, but there are no strong independent trials of the finished product, and its claims are cosmetic 'density/thickness,' not FDA regrowth. As a $20 daily cosmetic layered on top of a real minoxidil regimen it's harmless and affordable. Just be clear about what it is: a pleasant density serum with no strong independent evidence, not a proven regrowth drug — which is exactly why it ranks sixth.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Looksmaxxing guide →Weak, honestly scored. The peptide actives (Redensyl, Procapil, Capixyl, AnaGain) have data generated mostly by the ingredient suppliers, and there are no strong independent RCTs of the finished serum. Its claims are cosmetic density, not FDA regrowth. Above only the products with essentially no data (Vegamour, biotin); far below the proven drugs.
Plausible-ish. Caffeine and certain peptides have hand-wavy rationales for follicle support and anchoring, and caffeine may modestly affect the hair cycle in vitro. But these are cosmetic-grade mechanisms, not the characterized follicle biology of minoxidil or the anti-androgen action of ketoconazole.
A genuine strength: a lightweight, water-based leave-in serum is well tolerated, non-greasy, and contact-safe for daily scalp use, with low irritation risk. Minor deductions only for possible sensitivity to the actives or fragrance. Safe as an everyday cosmetic layer.
Cheap for the category — about $20 for a 60 ml bottle, roughly $20 a month at once-daily use. Good value as a cosmetic, and far better than the $48 Vegamour. But 'cheap' can't buy evidence it lacks, so it's good value for a cosmetic, not for a regrowth treatment.
High. Lightweight, non-greasy and pleasant, it slots into a daily routine easily — good adherence, no shed, no mess. The main limiter is motivation when results are cosmetic and subtle rather than dramatic.
“Supports hair density with a multi-peptide complex.”
The trademarked peptides (Redensyl/Procapil/Capixyl) have supplier-generated density data, and 'supports density' is a cosmetic claim the brand keeps non-drug. But there's no strong independent trial of the finished serum. Plausible cosmetic support, not proven regrowth.
“Caffeine energizes the scalp / follicles.”
Caffeine has some in-vitro and small-study signal on the hair cycle, but topical caffeine's real-world benefit in a cosmetic serum is unproven and likely minor. Marketing shorthand with a thread of rationale, not established efficacy.
“Visibly thicker, fuller-looking hair.”
'Looking' is the operative, honest word — cosmetic serums can improve the appearance of fullness (film-forming, conditioning) without changing follicle count. Defensible as a cosmetic appearance claim; not evidence of regrowth.
“A clinically proven alternative to minoxidil.”
There is no independent trial establishing this serum as comparable to minoxidil (Olsen 2002, PMID 12196747). Any such positioning is unsupported — it's a cosmetic density serum, a different and weaker category than an FDA-approved regrowth drug.
The Ordinary's virtue is candor and price: it's a $20 cosmetic that doesn't pretend to be $88 medicine, and the brand keeps its language to cosmetic 'density' rather than drug claims. That relative honesty, plus affordability, is why it's the most defensible product below the proven four.
The actives — Redensyl, Procapil, Capixyl, AnaGain — have data generated largely by the companies that sell them, and there's no strong independent RCT of the finished serum. Per SAC's source-provenance rule, ingredient-supplier data is not peer-reviewed proof, and shouldn't be read as such.
This is a cosmetic density/thickness product, not an FDA regrowth drug — a different, weaker category. It may make hair look fuller through conditioning and film-forming effects, but that's appearance, not follicle count. Don't expect it to move the needle on actual loss.
The reasonable use is as a lightweight, affordable cosmetic layered on top of minoxidil for people who already have the basics covered and enjoy the ritual. It's harmless and pleasant. As a standalone answer to thinning — or a substitute for the top four — it isn't the one, which is why it ranks sixth.
The Ordinary's hair serum is the most defensible product in the hype tier, mostly because it's honest about being cheap and doesn't cost $88. Its peptide actives have some supplier-generated data, and as a lightweight daily cosmetic layered on top of minoxidil it's harmless and affordable. But be clear about what it is: a cosmetic density serum with no strong independent evidence, not a proven regrowth drug. If you enjoy the ritual and the price doesn't sting, it's a fine adjunct. If you're choosing between this and the top four for actual results, this isn't the one — it ranks sixth for a reason. Spend on minoxidil first; add this only if you want a pleasant cosmetic layer on top.
Check The Ordinary · multi-peptide + caffeine leave-in scalp serum · 60 ml on AmazonThe proven regrowth drug this serum can only sit on top of — buy it first, at a third of Rogaine's price.
See it on the list →If you want a cheap topical with at least one real trial on its active, rosemary oil (Panahi 2015) beats supplier-only peptide data.
See it on the list →The oral route in the same weak-evidence tier — more credible ingredients but 4× the price and no better proof.
See it on the list →The FDA-approved regrowth benchmark this cosmetic serum is not — 5% minoxidil beat 2% and placebo over 48 weeks. The peptide serum has no comparable independent trial, which is the core reason it ranks in the honesty tier.
Even a cheap natural oil (rosemary) has one genuine comparative RCT behind its active; this peptide serum has only ingredient-supplier data — the contrast that places rosemary at #4 and this serum at #6.
